CAREDX INC (CDNA) Stock News

CareDx Announces Repurchase of 5% of Outstanding Shares

Johnson Fistel has Commenced an Investigation on Behalf of CareDx, Inc. Shareholders

CareDx to Participate in Upcoming Investor Conferences

Analyst Expectations For CareDx's Future

Earnings Scheduled For April 30, 2025

Mentions: AVB CMPR PPL LANC ...

CareDx (CDNA) Tops Q1 Earnings Estimates

CareDx (CDNA) delivered earnings and revenue surprises of 50% and 0.30%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

Mentions: SHC

CareDx Reports First Quarter 2025 Results

CareDx Announces New Data on AlloSure Lung Presented at 2025 International Society for Heart and Lung Transplantation Meeting

CareDx Announces Presentation of 60 Abstracts Including 19 Oral Presentations at the 2025 International Society for Heart and Lung Transplantation Meeting

CareDx Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)

CareDx to Report First Quarter 2025 Financial Results

CAREDX INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of CareDx, Inc. - CDNA

CareDx Launches Two Expanded Indications for AlloSure Testing Services

CAREDX INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of CareDx, Inc. - CDNA

CareDx Announces Fourth Quarter and Full Year 2024 Financial Results

CareDx Announces District Court Reverses Jury Decision in Patent Infringement Case Overturning Prior $96 Million Verdict

Johnson Fistel has Commenced an Investigation on Behalf of CareDx, Inc. Shareholders

CareDx Announces Presentation of Data at 2025 Tandem Meetings Demonstrating Strong Performance of AlloHeme in Early Relapse Detection for Hematologic Malignancies

CareDx to Report Fourth Quarter and Full Year 2024 Financial Results

CareDx Announces Preliminary Fourth Quarter and Full Year 2024 Results

CareDx to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

CareDx Partners with TC BioPharm to Support ACHIEVE Clinical Trial Using AlloCell for Pharmacokinetic Monitoring of Allogeneic Cell Therapy

TCBP Partners with CareDx to Support ACHIEVE Clinical Trial Using AlloCell for Pharmacokinetic Monitoring of Allogeneic Cell Therapy

/PRNewswire/ -- TC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP) a clinical-stage biotechnology company developing platform...

Mentions: TCBP

CareDx to Participate in Upcoming Investor Conferences